The Hedgehog and Wnt signalling pathways in cancer

Nature

Volumn 411, Issue 6835, 2001, Pages 349-354

  Taipale, Jussi ^a   Beachy, Philip A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; GENETIC ENGINEERING; PATHOLOGY; SKIN; TUMORS;

EMBRYONIC DEVELOPMENT;

DISEASES;

GENE PRODUCT; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

CANCER; CARCINOGENESIS; CELL COUNT; CELL FATE; CELL RENEWAL; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; GENE MUTATION; HUMAN; INTESTINE EPITHELIUM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; STEM CELL; TRANSCRIPTION INITIATION;

ANIMALS; BODY PATTERNING; COLONIC NEOPLASMS; HEDGEHOG PROTEINS; HUMANS; MUTATION; NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

ERINACEIDAE;

EID: 0035902140     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35077219     Document Type: Review

References (70)

1. Wodatz, A. & Nusse, R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell. Dev. Biol. 14, 59-88 (1998).
2. Polakis, P. Wnt Signaling and cancer. Genes Dev. 14, 1837-1851 (2000).
3. Bienz, M. & Clevers, H. Linking colorectal cancer to Wnt signaling. Cell 103, 311-320 (2000).
4. Ingham, P. W. Transducing hedgehog: the story so far. EMBO J. 17, 3505-3511 (1998).
5. Goodrich, L. V. & Scott, M. P. Hedgehog and patched in neural development and disease. Neuron 21, 1243-1257 (1998).
6. Muenke, M. & Beachy, P. A. in The Metabolic and Molecular Bases of Inherited Disease (eds Scriver, C., Beaudet, A., Sly, W. & Valle, D.) 6203-6230 (McGraw-Hill, New York, 2001).
7. McMahon, A. P. More surprises in the hedgehog signaling pathway. Cell 100, 185-188 (2000).
8. Lee, J. L. von Kessler, D. P., Parks, S. & Beachy, P. A. Secretion and localized transcription suggest a role in positional signaling for products of the segmentation gene hedgehog. Cell 71, 33-50 (1992).
9. Kalderon, D. Transducing the Hedgehog signal. Cell 103, 371-374 (2000).
10. Porter, J. A., Young, K. F. & Beachy, P. A. Cholesterol modification of Hedgehog signaling proteins in animal development. Science 274, 255-259 (1996).
11. Pepinsky, R. B. et al. Identification of a palmitic acid modified form of human Sonic hedgehog. J. Biol. Chem. 273, 14037-14045 (1998).
12. Baeg, G.-H. & Perrimon, N. Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila. Curr. Opin. Cell Biol. 12, 575-580 (2000).
13. Burke, R. et al. Dispatched, a novel sterol sensing domain protein dedicated to the release of cholesterol-modified Hedgehog from signaling cells. Cell 99, 803-815 (1999).
14. Davies, J. P., Chen, F. W. & Ioannou, Y. A. Transmembrane molecular pump activity Niemann-Pick C1 protein. Science 290, 2295-2298 (2000).
15. Stone, D. M. et al. The tumor-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384, 129-134 (1996).
16. Denef, N., Neubuset, D., Perez, I. & Cohen, S. M. Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened. Cell 102, 521-531 (2000).
17. Taipale, J. et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005-1009 (2000).
18. Aza-Blanc, P., Remirez-Weber, F.-A., Laget, M.-P., Schwartz, C. & Kornberg, T. B. Proteolysis that is inhibited by Hedgehog targets cubitus interruptus protein to the nucleus and converts it to a repressor. Cell 89, 1043-1053 (1997).
19. Robbins, D. J. et al. Hedgehog elicits signal transduction by means of a large complex containing the kinesin-related protein Costal2. Cell 90, 225-234 (1997).
20. Chen, C. H. et al. Nuclear trafficking of Cubitus interruptus in the trancriptional regulation of Hedgehog target gene expression. Cell 98, 305-16 (1999).
21. Freeman, M. Feedback control of intercellular signalling in development. Nature 408, 313-319 (2000).
22. Park, H. L. et al. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127, 1593-1605 (2000).
23. Hobmayer, B. et al. WNT signalling molecules act in axis formation in the diploblastic metozan Hydro. Nature 407, 186-189 (2000).
24. Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J. & Skarnes, W. C. An LDI-receptor-related protein mediates Wnt signalling in mice. Nature 407, 535-538 (2000).
25. Bhanot, P. et al. A new member of the Frizzled family from Drosophila functions as a Wingless receptor. Nature 282, 225-230 (1996).
26. Behrens, J. et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996)
27. Nusse, R. & Varmus, H. F. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31, 99-109 (1982).
28. Morin, P. J. et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (1997).
29. Lickert, H. et al. Wnt/β-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 127, 3805-3813 (2000).
30. He, T.-C. et al. Identification of c-Myc as a target of the APC pathway. Science 281, 1509-1512 (1998).
31. Shih, I.-M., Yu, J., He, T.-C., Vogelstein, B. & Kinzler, K. W. The β-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res. 60, 1671-1676 (2000).
32. Johnson, R. L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-1671 (1996).
33. Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851 (1996).
34. Xie, J. et al., Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391, 90-92 (1998).
35. Lam, C.-W. et al. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18, 833-836 (1999).
36. Nilsson, M. et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing Gli-1. Proc. Natl Acad. Sci. USA 97, 3438-3443 (2000).
37. Bray, S. A Notch affair. Cell 93, 499-503 (1998).
38. Massagué, J., Blain, S. W. & Lo, R. S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309 (2000).
39. Taipale, J., Saharinen, I. & Keski-Oja, J. Extracellular matrix-associated transforming growth factor-β: activation and roles in cancer cell growth and invasion. Adv. Cancer Res. 75, 87-134 (1998).
40. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
41. Brash, D. E. & Pontén, J. Skin precancer. Cancer Surv. 32, 69-113 (1998).
42. Jonason, A. S. et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA 93, 14025-14029 (1996).
43. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730-737 (1997).
44. Xie, T. & Spradling, A. C. A Niche maintaining germ line stem cells in the Drosophila ovary. Science 290, 328-330 (2000).
45. Zhang, Y. & Kalderon, D. Hedgehog acts as a somatic stem cell factor in the Drosophila ovary. Nature 410, 599-604 (2001).
46. Fuchs, E. & Segre, J. A. Stem cells: a new lease on life. Cell 100, 143-155 (2000).
47. Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
48. Booth, C. & Potten, C. Gut instincts: thoughts on intestinal epithelial stem cells. J. Clin. Invest. 105, 1493-1499 (2000).
49. Campbell, F. et al. Post-irradiation somatic mutation and clonal stabilisation time in the human colon. Gut 39, 569-573 (1996).
50. Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet. 19, 379-383 (1998).
51. Moser, A. R., Dove, W. F., Roth, K. A. & Gordon, J. I. The Min (multiple intestinal neoplasia) mutation: its effects on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol. 116, 1517-1526 (1992).
52. Alder, I., Cho, N. K. & Hatten, M. E. Embryonic precursor cells from the rhombic lip are specified to a cerebellar granule neuron identity. Neuron 17, 389-399 (1996).
53. Wechsler-Reya, R. J. & Scott, M. P. The developmental biology of brain tumors. Annu. Rev. Neurosci. 24, 385-428 (2001).
54. Kenney, A. M. & Rowitch, D. H. Sonic hedgehog promotes G1 cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol. Cell. Biol. 20, 9055-9067 (2000).
55. Miyazawa, K. et al. A Role for p27/Kip1 in the control of cerebellar granule cell precursor proliferation. J. Neurosci. 20, 5756-5763 (2000).
56. Pietsch, T. et al. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res. 57, 2085-2088 (1997).
57. Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J. & Berns, A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer of the cerebellum. Genes Dev. 14, 994-1004 (2000).
58. Schiffer, D. et al. Cell-cycle inhibitor p27/Kip-1 expression in non-astrocylic and non-oligodendrocytic human nervous system tumors. Neurosci. Lett. 264, 29-32 (1999).
59. Krüger, K., Blame-Peytavi, U. & Orfanos, C. E. Basal cell carcinoma possibly originates from the outer root sheath and/or the bulge region of the vellus hair follicle. Arch. Dermatol. Res. 291, 253-259 (1999).
60. St-Jacques, B. et al. Sonic hedgehog signaling is essential for hair development. Curr. Biol. 8, 1058-1068 (1998).
61. Sato, N., Leopold, L. P. & Crystal, R. G. Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog. J. Clin. Invest. 104, 855-864 (2000).
62. Gibbs, J. B. Mechanism-based target identification and drug discovery in cancer research. Science 287, 1969-1973 (2000).
63. Hahn, W. C. et al. Creation of human tumor cells with defined genetic elements. Nature 400, 464-468 (1999).
64. Elenbaas, B. et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65 (2001).
65. Conlon, I. & Raff, M. Size control in animal development. Cell 96, 235 (1999).
66. Counter, C. M. et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl Acad. Sci. USA 95, 14723-14728 (1998).
67. Tsao, J.-L. et al. Tracing cell fates in human colorectal tumors from somatic microsatellite mutations: evidente for adenomas with stem cell architecture. Am. J. Pathol. 153, 1189-1200 (1998).
68. Tejpar, S. et al. Predominance of β-catenin mutations and β-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18, 6615-6620 (1999).
69. Wei, Y. et al. Activation of β-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19, 498-504 (2000).
70. Sparks, A. B., Morin, P. J., Vogelstein, B. & Kinzler, K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130-1134 (1998).